Portia Ofori Shore, NP
Nurse Practitioner · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Portia Ofori Shore’s office to ask if they take your plan before you enroll.
Original Medicare doctor bills
$52,129
Medicare paid this office $52,129 for 359 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 207 | $27,755 | $134 |
| Return visit (30+ min) | 110 | $9,983 | $81 |
| Short return visit (20+ min) | 26 | $1,664 | $64 |
| Complete ultrasound scan behind abdominal cavity | 16 | $1,206 | $75 |
| Ultrasound measurement of bladder capacity after voiding | 81 | $822 | $10 |
See all 7 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 207 | $27,755 | $134 |
| Return visit (30+ min) | 110 | $9,983 | $81 |
| Short return visit (20+ min) | 26 | $1,664 | $64 |
| Complete ultrasound scan behind abdominal cavity | 16 | $1,206 | $75 |
| Ultrasound measurement of bladder capacity after voiding | 81 | $822 | $10 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 28 | $326 | $12 |
| Automated urinalysis test | 104 | $262 | $2 |
Who their Medicare patients are
359 Original Medicare patients in 2024. Average age 76 · Women 42% · Also on Medicaid 6% · Health risk score 1.39. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 74% · Coronary heart disease 37% · Diabetes 31% · Chronic kidney disease 26% · Cancer 26% · Atrial fibrillation 26% · Depression 23% · Heart failure 20% · COPD 16% · Stroke 9% · Dementia 8%.
The office billed $188,584, Medicare allowed $60,615 and paid $52,129; for 950 services of 29 kinds; $6,048 of it was for drugs given in the office and $46,081 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 359 | 950 | 76 | 1.39 | $188,584 | $52,129 |
| 2023 | 122 | 668 | 76 | 1.12 | $119,366 | $19,924 |
| 2020 | 28 | 481 | 77 | 1.61 | $10,621 | $3,508 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 81 | $8,038 | $92 |
| Short return visit (20+ min) | 17 | $1,132 | $67 |
| Complete ultrasound scan of pelvis | 11 | $793 | $72 |
| Ultrasound measurement of bladder capacity after voiding | 54 | $537 | $10 |
| Automated urinalysis test | 78 | $189 | $2 |
2020: 2 services
| Short return visit (20+ min) | 17 | $904 | $53 |
| Automated urinalysis test | 13 | $38 | $2 |
Drugs they prescribed that Part D paid
$177,371
Pharmacies billed $177,371 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,000 generic and fewer than 11 brand-name prescriptions · $177,371 in drug cost · 66 antibiotic prescriptions to 54 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gemtesa | 75 | $76,074 | $1,014 |
| Myrbetriq | 50 | $38,534 | $771 |
| Xyosted | 38 | $29,173 | $768 |
| Silodosin | 76 | $7,318 | $96 |
| Tamsulosin | 340 | $5,698 | $17 |
See all 16 drugs
| Gemtesa | 75 | $76,074 | $1,014 |
| Myrbetriq | 50 | $38,534 | $771 |
| Xyosted | 38 | $29,173 | $768 |
| Silodosin | 76 | $7,318 | $96 |
| Tamsulosin | 340 | $5,698 | $17 |
| Finasteride | 240 | $3,574 | $15 |
| Potassium Citrate Er | 28 | $3,110 | $111 |
| Solifenacin | 41 | $3,092 | $75 |
| Fesoterodine Fumarate Er | 18 | $1,522 | $85 |
| Alfuzosin Hcl Er | 60 | $1,323 | $22 |
| Bethanechol Chloride | 21 | $1,155 | $55 |
| Dutasteride | 33 | $966 | $29 |
| Nitrofurantoin Mono-Macro | 12 | $210 | $18 |
| Ciprofloxacin | 16 | $144 | $9 |
| Amoxicillin-Clavulanate Potass | 17 | $100 | $6 |
| Sulfamethoxazole-Trimethoprim | 12 | $81 | $7 |
Year by year
| 2024 | 1,170 | 336 | None | None | $177,371 |
| 2023 | 1,768 | 482 | None | 11% | $254,532 |
| 2022 | 1,711 | 488 | None | None | $191,920 |
| 2021 | 1,308 | 367 | None | 7% | $141,961 |
| 2020 | 602 | 255 | None | 13% | $67,306 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Gemtesa | 95 | $82,162 | $865 |
| Myrbetriq | 51 | $58,993 | $1,157 |
| Xyosted | 37 | $33,478 | $905 |
| Solifenacin | 72 | $13,885 | $193 |
| Silodosin | 85 | $12,506 | $147 |
| Tamsulosin | 539 | $11,398 | $21 |
| Finasteride | 380 | $6,732 | $18 |
| Dutasteride | 67 | $5,352 | $80 |
| Potassium Citrate Er | 27 | $4,076 | $151 |
| Alfuzosin Hcl Er | 114 | $3,449 | $30 |
| Fesoterodine Fumarate Er | 11 | $2,547 | $232 |
| Oxybutynin Chloride Er | 16 | $1,300 | $81 |
| Bethanechol Chloride | 30 | $1,187 | $40 |
| Ciprofloxacin | 52 | $491 | $9 |
| Nitrofurantoin Mono-Macro | 15 | $359 | $24 |
| Duloxetine | 20 | $288 | $14 |
| Hydroxyzine | 15 | $195 | $13 |
| Oxybutynin Chloride | 15 | $111 | $7 |
| Sulfamethoxazole-Trimethoprim | 13 | $68 | $5 |
2022: 20 drugs
| Myrbetriq | 60 | $55,406 | $923 |
| Xyosted | 29 | $29,215 | $1,007 |
| Gemtesa | 27 | $17,716 | $656 |
| Solifenacin | 67 | $14,879 | $222 |
| Silodosin | 86 | $14,104 | $164 |
| Tamsulosin | 501 | $9,892 | $20 |
| Finasteride | 420 | $7,156 | $17 |
| Dutasteride | 61 | $5,888 | $97 |
| Potassium Citrate Er | 38 | $5,052 | $133 |
| Toviaz | 11 | $4,477 | $407 |
| Alfuzosin Hcl Er | 105 | $2,610 | $25 |
| Oxybutynin Chloride Er | 16 | $1,527 | $95 |
| Duloxetine | 15 | $1,240 | $83 |
| Bethanechol Chloride | 16 | $743 | $46 |
| Nystatin-Triamcinolone | 12 | $311 | $26 |
| Nitrofurantoin Mono-Macro | 19 | $308 | $16 |
| Ciprofloxacin | 48 | $252 | $5 |
| Hydroxyzine | 25 | $100 | $4 |
| Cephalexin | 13 | $82 | $6 |
| Sulfamethoxazole-Trimethoprim | 22 | $71 | $3 |
2021: 15 drugs
| Myrbetriq | 58 | $47,857 | $825 |
| Xyosted | 12 | $14,099 | $1,175 |
| Testosterone | 18 | $11,963 | $665 |
| Silodosin | 66 | $11,229 | $170 |
| Finasteride | 373 | $8,220 | $22 |
| Tamsulosin | 393 | $8,008 | $20 |
| Solifenacin | 34 | $7,448 | $219 |
| Dutasteride | 35 | $4,259 | $122 |
| Potassium Citrate Er | 27 | $3,844 | $142 |
| Alfuzosin Hcl Er | 69 | $1,908 | $28 |
| Oxybutynin Chloride Er | 20 | $1,076 | $54 |
| Duloxetine | 18 | $765 | $42 |
| Cephalexin | 15 | $279 | $19 |
| Ciprofloxacin | 22 | $86 | $4 |
| Hydroxyzine | 16 | $82 | $5 |
2020: 12 drugs
| Myrbetriq | 32 | $17,644 | $551 |
| Xyosted | 14 | $8,989 | $642 |
| Silodosin | 45 | $8,870 | $197 |
| Toviaz | 12 | $5,708 | $476 |
| Finasteride | 144 | $3,333 | $23 |
| Tamsulosin | 136 | $3,151 | $23 |
| Dutasteride | 17 | $1,613 | $95 |
| Duloxetine | 20 | $698 | $35 |
| Solifenacin | 12 | $679 | $57 |
| Alfuzosin Hcl Er | 24 | $647 | $27 |
| Bethanechol Chloride | 12 | $520 | $43 |
| Ciprofloxacin | 21 | $207 | $10 |
Money from drug and device companies
$24 in 2025
| 2025 | 1 | 1 | None | $24 |
| 2024 | 11 | 18 | None | $404 |
| 2023 | 13 | 36 | None | $807 |
| 2022 | 18 | 34 | None | $884 |
| 2021 | 12 | 32 | None | $814 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Accord Healthcare | Camcevi | $24 | 1 payment
|
See the published payment
| Accord Healthcare | Meals · 2025-04-08 | Camcevi | $24 |
See earlier years (2024, 2023, 2022, 2021)
2024: $404
| Antares Pharma | Xyosted | $97 | 4 payments
|
| Accord Healthcare | Camcevi | $44 | 2 payments
|
| Abbvie | Lupron Depot | $42 | 2 payments
|
| Astellas Pharma US | Xtandi | $39 | 2 payments
|
| Tolmar | Eligard | $37 | 2 payments
|
| Olympus America | Itind System | $35 | 1 payment
|
| Endo Pharmaceuticals | Xiaflex | $25 | 1 payment
|
| Blue Earth Diagnostics | Posluma | $24 | 1 payment
|
| Ferring Pharmaceuticals | Adstiladrin | $23 | 1 payment
|
| Endo USA | Xiaflex | $22 | 1 payment
|
| Novo Nordisk | None | $17 | 1 payment
|
2023: $807
| Merck Sharp & Dohme | Keytruda | $196 | 8 payments
|
| Blue Earth Diagnostics | Posluma | $101 | 4 payments
|
| Tolmar | Eligard | $86 | 4 payments
|
| Accord Healthcare | Camcevi | $74 | 3 payments
|
| Abbvie | Lupron Depot | $66 | 3 payments
|
| Endo Pharmaceuticals | Xiaflex | $61 | 3 payments
|
| Janssen Biotech | Erleada | $53 | 3 payments
|
| Progenics Pharmaceuticals | Pylarify | $46 | 2 payments
|
| Sumitomo Pharma America | Gemtesa | $40 | 2 payments
|
| Coloplast | Speedicath | $28 | 1 payment
|
| Teleflex | Urolift | $23 | 1 payment
|
| Supernus Pharmaceuticals | Tlando | $20 | 1 payment
|
| Antares Pharma | Xyosted | $13 | 1 payment
|
2022: $884
| Astellas Pharma US | None | $177 | 2 payments
|
| Merck Sharp & Dohme | Keytruda | $94 | 4 payments
|
| Olympus America | Itind System | $85 | 3 payments
|
| Blue Earth Diagnostics | Axumin | $78 | 3 payments
|
| Abbvie | Lupron Depot | $76 | 4 payments
|
| Pfizer | Xtandi | $48 | 2 payments
|
| Urovant Sciences | Gemtesa | $41 | 2 payments
|
| Antares Pharma | Nocdurna | $39 | 2 payments
|
| Progenics Pharmaceuticals | Pylarify | $37 | 2 payments
|
| 180 Medical | None | $30 | 1 payment
|
| Janssen Biotech | Erleada | $29 | 1 payment
|
| Acerus Pharmaceuticals | Natesto | $24 | 2 payments
|
| PROCEPT BioRobotics | Aquabeam Robotic System | $23 | 1 payment
|
| Boston Scientific | Upsylon | $23 | 1 payment
|
| Myriad Genetic Laboratories | Brac Cdx | $23 | 1 payment
|
| ABC Home Medical Supply | None | $20 | 1 payment
|
| Novo Nordisk | Saxenda | $20 | 1 payment
|
| TOLMAR Pharmaceuticals | Eligard | $18 | 1 payment
|
2021: $814
| Antares Pharma | Nocdurna | $221 | 6 payments
|
| AbbVie | Ubrelvy | $177 | 8 payments
|
| Blue Earth Diagnostics | Axumin | $126 | 5 payments
|
| Myovant Sciences | Orgovyx | $54 | 3 payments
|
| Pfizer | Xtandi | $49 | 2 payments
|
| TOLMAR Pharmaceuticals | Eligard | $46 | 2 payments
|
| Teleflex | Urolift System | $31 | 1 payment
|
| 180 Medical | None | $29 | 1 payment
|
| Endo Pharmaceuticals | Xiaflex | $22 | 1 payment
|
| Myriad Genetic Laboratories | Bracanalysis Cdx | $22 | 1 payment
|
| Progenics Pharmaceuticals | Pylarify | $21 | 1 payment
|
| Sagent Pharmaceuticals | Glydo | $16 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 84.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1386274819
- Licence
- CA 95013736
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 17328 Ventura Blvd # 108, Encino, CA, 91316
- NPI first listed
- 2020-01-23
- NPI last updated
- 2021-10-25
- NPI record certified
- 2021-10-25
This is when the NPI record was last certified, not a medical board exam.